Dow develops new p[olymeric FR Technology
Chemical

Dow develops new p[olymeric FR Technology

Dow Global Technologies LLC (DGTL), a subsidiary of The Dow Chemical Co., on Tuesday announced the invention and development of a new, high molecular weight brominated Polymeric Flame Retardant (Polymeric FR). The Polymeric FR is expected to be the \

  • By ICN Bureau | March 31, 2011

Dow Global Technologies LLC (DGTL), a subsidiary of The Dow Chemical Co., on Tuesday announced the invention and development of a new, high molecular weight brominated Polymeric Flame Retardant (Polymeric FR). The Polymeric FR is expected to be the 'next generation industry standard' flame retardant for use in both extruded polystyrene (XPS) and expanded polystyrene (EPS) foam insulation applications globally. The development of the new Polymeric FR is the result of Dow's continuing search for more sustainable products and in this case for a flame retardant that can replace hexabromocyclododecane (HBCD).

Phased Commercialization Plans by licensees

DGTL also announced the first license agreement with Chemtura Corp. This first license agreement makes it possible for Great Lakes Solutions, a Chemtura business, to produce and sell the newly developed Polymeric FR for use in XPS and EPS foam. DGTL is currently engaged in advanced licensing discussions with several other interested companies and expects to finalize these agreements by the end of the year. DGTL expects this will enable global supply security, foster market competition and help facilitate a smooth industry conversion to the new technology as EPS and XPS manufacturers adopt Polymeric FR, thereby becoming the new global standard.

To enable formulation optimizations and market qualifications, it is expected that Polymeric FR licensees will have interim quantities available throughout 2011. This will be followed, likely in 2012, by large plant construction by the licensees, making significantly larger commercial volumes available by 2013-2015 that are in line with the current HBCD market demand. This should allow the global polystyrene foam insulation industry to make a smooth transition, as national regulations are implemented.

The development of Dow's Polymeric FR technology comes against the backdrop of an ongoing search for more sustainable products and pending regulatory restrictions on HBCD initiated by the European Union's Registration, Evaluation, Authorization and Restriction of Chemical (REACH) substances program and several other national regulations.

Breakthrough Sustainable Chemistry

The Polymeric FR is a stable, high molecular weight, Non-PBT (Persistent, Bioaccumulative, Toxic) substance that has been subjected to an extensive and robust Environment, Health & Safety (EH&S) testing regimen and evaluation, confirming a more sustainable profile. Furthermore, it provides a fire safety solution for EPS and XPS foams to enable these thermal insulation materials to continue to meet the increasing demands of global energy efficiency regulations.

Dow's Polymeric FR technology is the result of several years of research and development efforts, including significant investments led by The Dow Chemical Company that leverage the company's polymer, chemistry, and process science and applications know-how and EH&S expertise. Dow has worked with potential licensees to validate the technology and enable them to start scaling up a commercially viable production process.
 

Register Now to Attend NextGen Chemicals & Petrochemicals Summit 2024, 11-12 July 2024, Mumbai

Other Related stories

Startups

Petrochemical

Energy

Digitization

Aim to become import substitute for instrumentation business in India
Aim to become import substitute for instrumentation business in India
Vinayak M. Patankar, Sreejith Kumar Whole Time Director & CEO, Borosil Scientific Ltd. , Associate Vice President - Design, Borosil Scientific Ltd.

Looking at increasing manufacturing base outside India
Looking at increasing manufacturing base outside India
Sidharth A. Choksi Executive Vice President, Hindustan Platinum Pvt. Ltd

Developing new products like Vitamin B1 and Vitamin B6
Developing new products like Vitamin B1 and Vitamin B6
Hemal Mehta, Sachin Mehta Chairman, Sudarshan Pharma Industries Ltd. & Managing Director, Sudarshan Pharma Industries Ltd.